Stonepine Capital Management, LLC I Mab Put Options Transaction History
Stonepine Capital Management, LLC
- $103 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IMAB
# of Institutions
38Shares Held
13.8MCall Options Held
20KPut Options Held
13.3K-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$5.26 Million0.15% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.17MShares$3.67 Million3.04% of portfolio
-
Sg Americas Securities, LLC822KShares$723,3960.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny363KShares$319,6160.0% of portfolio
-
Ubs Group Ag319KShares$280,3200.0% of portfolio
About I-Mab
- Ticker IMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,098,800
- Market Cap $73.1M
- Description
- I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...